Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Carcinoma In Situ 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tumor Response Rate 1Thrombosis 1Small Cell Lung Carcinoma 1Sarcoma 1Radiation Therapy 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Nasopharyngeal Cancer Recurrent 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Nasopharyngeal Cancer Recurrent × Radiotherapy, Conformal × Clear all
NCT02113423 2014-04-14

Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma

Fujian Cancer Hospital

Phase NA Completed
168 enrolled
Head & Neck

Nasopharyngeal Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡